Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Indapamix-SR 1.5 Indapamide Sustained Release Tablets, 1.5 mg
Indapamix-SR 1.5, provided by Lexaro Healthcare, contains 1.5 mg of Indapamide in each sustained-release tablet. This formulation is designed to provide effective management of hypertension (high blood pressure) and fluid retention, promoting cardiovascular health.
Uses of Indapamix-SR 1.5 Indapamide Sustained Release Tablets, 1.5 mg
Indapamix-SR 1.5 is primarily prescribed for the treatment of hypertension (high blood pressure). It is also used to manage fluid retention (edema) associated with heart failure and other medical conditions. By reducing excess fluid in the body, it helps to lower blood pressure and decrease the workload on the heart.
Benefits of Indapamix-SR 1.5 Indapamide Sustained Release Tablets, 1.5 mg
Provides effective treatment for hypertension.
Helps manage fluid retention (edema).
Promotes cardiovascular health by lowering blood pressure.
Sustained-release formulation ensures steady medication levels throughout the day.
Convenient once-daily dosing for improved patient compliance.
Well-tolerated with a favorable safety profile when used as directed.
Mechanism of Action of Indapamix-SR 1.5 Indapamide Sustained Release Tablets, 1.5 mg
Indapamide is a thiazide-like diuretic that works by inhibiting the reabsorption of sodium and chloride ions in the distal convoluted tubule of the kidney. This action increases the excretion of sodium, chloride, and water, reducing fluid retention. Additionally, Indapamide has a direct vasodilatory effect on the blood vessels, which helps to lower blood pressure. The sustained-release formulation ensures a gradual release of the medication, providing prolonged therapeutic effects and improving blood pressure control throughout the day.